SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039297
Filing Date
2020-08-11
Accepted
2020-08-11 16:07:10
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rna-10q_20200630.htm 10-Q 2136057
2 EX-31.1 rna-ex311_9.htm EX-31.1 10340
3 EX-31.2 rna-ex312_8.htm EX-31.2 10163
4 EX-32.1 rna-ex321_7.htm EX-32.1 6782
5 EX-32.2 rna-ex322_6.htm EX-32.2 6770
  Complete submission text file 0001564590-20-039297.txt   6418687

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rna-20200630.xml EX-101.INS 1049248
7 XBRL TAXONOMY EXTENSION SCHEMA rna-20200630.xsd EX-101.SCH 57331
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rna-20200630_cal.xml EX-101.CAL 43775
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rna-20200630_def.xml EX-101.DEF 180685
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20200630_lab.xml EX-101.LAB 434424
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20200630_pre.xml EX-101.PRE 334542
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39321 | Film No.: 201092469
SIC: 2834 Pharmaceutical Preparations